Skip to content

Dr. Justine Werbrouck

Active Private limited companyfounded 2017active for 9 yearsLeonard Vandorpestraat 22, 8500 KortrijkKBO/BCE: BE 0672.430.328

Lifetime

8 annual accounts with figures on one time axis
peak of €179,531 in 2024
€172,685▼ 3.8%
lowest -€45,490 in 2019
€113,203▼ 1.6%
peak of €96,644 in 2024
€20,416▼ 78.9%
€222,928▲ 63.4%
Board1 name since 2017
1 director
Documentsfilings and deeds
06-07-202625 days before the deadline
2025micro format
Dividend €188,000Equity from €96,644 to €20,416Debts from €136,452 to €222,928Cash from €97,870 to €56,388

Key points

from the 2025 annual accounts

Equity

€20,416 from €96,644 in 2024

Equity fell by 79% in 1 year.

Turnover

≈ €340,000 estimated

The micro format states no turnover.

Debts

€222,928 92% of the balance sheet
Suppliers 0%Taxes and wages 13%Other 87%

Of this, €205,605 falls due within a year.

Liquidity

1.03 was 1.71 in 2024

Short-term debts rose from €116,281 to €205,605.

Filings

8 annual accounts since 2018
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 24 to 32 days before the end of the period.

Position in the sector

8.4%

Lower solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dr. Justine Werbrouck has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dr. Justine Werbrouck. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 06-03-2017
  • all the sharesdeed of 06-10-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0672430328
Registered office moved within Kortrijk The registered office moved from Watertorenhoek 15, 8500 Kortrijk to Leonard Vandorpestraat 22, 8500 Kortrijk · Board meeting of 03-11-2023 · Gazette deed
Company renamed to DR. JUSTINE WERBROUCK “tekst zoals hierna opgenomen in negende besluit onder titel voorwerp” (deed in Dutch) · holds all the shares · General meeting of 01-10-2021 · Gazette deed
Registered office moved within Kortrijk The registered office moved from Sint-Sebastiaanslaan 78, 8500 Kortrijk, België to Watertorenhoek 15, 8500 Kortrijk · Board meeting of 03-07-2019 · Gazette deed
All 19 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Justine Werbrouck Kortrijk €243,344 €172,685 8.4% -
ALBECESA Uccle €230,568 €172,617 81.6% -
LC LAB La Louvière €276,778 €164,808 52.3% -
TOOP Leuven €239,284 €175,510 23.5% 2.8
Dr. Philippe DECLERCK, nucleaire geneeskunde Leuven €182,116 €181,396 88.4% 0
DR. LIEN VANDEBUERIE Roeselare €181,977 €166,703 10.3% -
MICHASO Cerfontaine €337,688 €161,993 72.0% -

These companies have the same main activity as Dr. Justine Werbrouck: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €182,000 and €338,000, founded between 2014 and 2019.

Official details

Source: KBO
Status
Active since 06-03-2017Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910and 1 other
Joint committee
330Health institutions and services · annual accounts 2021
Establishment unit
2.262.161.3488500 Kortrijk, since 06-03-2017
Financial year end
31 December
Peppol
Reachable since 17-07-2026
Company details

Annual accounts 2025

€243,344▲ 4.4%
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on Dr. Justine Werbrouck

Dr. Justine Werbrouck files the micro format. That format states no turnover. The gross margin rose from €86,990 in 2018 to €172,685 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Justine Werbrouck

What is the company number of Dr. Justine Werbrouck?
The company number of Dr. Justine Werbrouck is 0672.430.328. The VAT number is the same number with BE in front: BE 0672.430.328.
Where is Dr. Justine Werbrouck based?
The registered office is at Leonard Vandorpestraat 22, 8500 Kortrijk.Company details
What does Dr. Justine Werbrouck do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of Dr. Justine Werbrouck?
Dr. Justine Werbrouck is a private limited company (BV).
When was Dr. Justine Werbrouck founded?
Dr. Justine Werbrouck was founded on 06-03-2017.
Is Dr. Justine Werbrouck still active?
Yes, Dr. Justine Werbrouck is an active enterprise in the KBO register.
How many employees does Dr. Justine Werbrouck have?
Dr. Justine Werbrouck had an average of 0.5 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
Which joint committee does Dr. Justine Werbrouck fall under?
In its 2021 annual accounts, Dr. Justine Werbrouck states joint committee 330 (Health institutions and services).
What is the turnover of Dr. Justine Werbrouck?
The turnover in financial year 2025 is about €340,000. This figure is estimated from the gross margin of €172,685 and 84 comparable companies (NACE 86). It probably lies between €260,000 and €430,000.
Is Dr. Justine Werbrouck profitable?
In financial year 2025, Dr. Justine Werbrouck made a profit of €113,203.
Where can I find the annual accounts of Dr. Justine Werbrouck?
Dr. Justine Werbrouck filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Justine Werbrouck due?
Dr. Justine Werbrouck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.